Most interestingly, in murine cancer models, high-IDO activity, resulting in accelerated tumor progression, is associated to immune responses and to high expression in the tumor microenvironment of pro-inflammatory cytokines, including IFN-γ and TNF-α (37). Here, IDO1 is linked to cancer.